MPH.V MCUJF $1 Canadian Just under 6x earnings at current prices. Not bad for a healthcare stock with this type of revenue growth. This stock has potential 200% upside I think. Depending on the terms of the deal the Apicore acquisition could be highly accretive. Possibly boosting EPS by 25% or more. The option to acquire Apicore ends next July.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.